Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kannan Manickam

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
World Journal of Urology|April 30, 2003
Herbal and complementary medicine in chronic prostatitisDaniel A Shoskes, Kannan Manickam
Pediatric Surgery International|February 25, 2003
Concealed penisJayant Radhakrishnan, Asim Razzaq, Kannan Manickam
Urologic Oncology|July 15, 2022
Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter studyEric A Klein, Alan Partin, Yair Lotan, et al.
European Urology|April 12, 2017
The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary ReportEric A Klein, Arnon Chait, Jason M Hafron, et al.
Urology|February 22, 2023
IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation StudyJason M Scovell, Mark Stovsky, Alan Partin, et al.
The Journal of Urology|February 28, 2019
Clinical Validation of IsoPSA™, a Single Parameter, Structure Based Assay for Improved Detection of High Grade Prostate CancerMark Stovsky, Eric A Klein, Arnon Chait, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
World Journal of Urology|April 30, 2003
Herbal and complementary medicine in chronic prostatitisDaniel A Shoskes, Kannan Manickam
Pediatric Surgery International|February 25, 2003
Concealed penisJayant Radhakrishnan, Asim Razzaq, Kannan Manickam
Urologic Oncology|July 15, 2022
Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter studyEric A Klein, Alan Partin, Yair Lotan, et al.
European Urology|April 12, 2017
The Single-parameter, Structure-based IsoPSA Assay Demonstrates Improved Diagnostic Accuracy for Detection of Any Prostate Cancer and High-grade Prostate Cancer Compared to a Concentration-based Assay of Total Prostate-specific Antigen: A Preliminary ReportEric A Klein, Arnon Chait, Jason M Hafron, et al.
Urology|February 22, 2023
IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation StudyJason M Scovell, Mark Stovsky, Alan Partin, et al.
The Journal of Urology|February 28, 2019
Clinical Validation of IsoPSA™, a Single Parameter, Structure Based Assay for Improved Detection of High Grade Prostate CancerMark Stovsky, Eric A Klein, Arnon Chait, et al.
Pageof 1